Albright, J D <br/><br/>
5-Fluoro-2-methyl-N-[4-(5H-pyrrolo[2,1-c]-[1, 4]benzodiazepin-10(11H)-ylcarbonyl)-3-chlorophenyl]benzamide (VPA-985): an orally active arginine vasopressin antagonist with selectivity for V2 receptors.  [electronic resource] 

 -  Journal of medicinal chemistry  Jul 1998 
 - 2442-4 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0022-2623 
<br/><br/><label>Standard No.: </label>10.1021/jm980179c  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Animals<br/>Arginine Vasopressin--antagonists & inhibitors<br/>Azepines--administration & dosage<br/>Benzamides--administration & dosage<br/>Blood Platelets--metabolism<br/>Body Water--metabolism<br/>Cell Line<br/>Cell Membrane--metabolism<br/>Dogs<br/>Fibroblasts--drug effects<br/>Humans<br/>Kidney--metabolism<br/>Liver--metabolism<br/>Osmolar Concentration<br/>Pyrroles<br/>Rats<br/>Receptors, Vasopressin--metabolism<br/>Sodium--blood<br/>Structure-Activity Relationship<br/>Urine--chemistry